[(3R)-3-aminopiperidin-1-yl]-[4-[3-(1-benzofuran-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanone
C27H24N4O2 — CID 177376562
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3R)-3-aminopiperidin-1-yl]-[4-[3-(1-benzofuran-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanone
[(3R)-3-aminopiperidin-1-yl]-[4-[3-(1-benzofuran-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanone (PubChem CID 177376562) has the molecular formula C27H24N4O2 and a molecular weight of 436.52 g/mol. Its IUPAC name is [(3R)-3-aminopiperidin-1-yl]-[4-[3-(1-benzofuran-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanone.
Molecular Properties
| Compound Name | [(3R)-3-aminopiperidin-1-yl]-[4-[3-(1-benzofuran-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanone |
|---|---|
| PubChem CID | 177376562 |
| Molecular Formula | C27H24N4O2 |
| Molecular Weight | 436.52 g/mol |
| Exact Mass | 436.19 |
| IUPAC Name | [(3R)-3-aminopiperidin-1-yl]-[4-[3-(1-benzofuran-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanone |
| SMILES | N[C@@H]1CCCN(C(=O)c2ccc(-c3ccc4ncc(-c5cc6ccccc6o5)n4c3)cc2)C1 |
| InChI | InChI=1S/C27H24N4O2/c28-22-5-3-13-30(17-22)27(32)19-9-7-18(8-10-19)21-11-12-26-29-15-23(31(26)16-21)25-14-20-4-1-2-6-24(20)33-25/h1-2,4,6-12,14-16,22H,3,5,13,17,28H2/t22-/m1/s1 |
| InChIKey | VQBHHVIUAXNAOC-JOCHJYFZSA-N |
| XLogP | 4.98 |
| TPSA | 76.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.52 |
| LogP ≤ 5 | 4.98 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177376562 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.